Literature DB >> 26821339

Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assays.

Yuto Amano1, Akihiro Nishiguchi1, Michiya Matsusaki1, Hiroko Iseoka2, Shigeru Miyagawa2, Yoshiki Sawa2, Manabu Seo3, Takashi Yamaguchi3, Mitsuru Akashi4.   

Abstract

In vitro development of three-dimensional (3D) human cardiomyocyte (CM) tissues derived from human induced pluripotent stem cells (iPSCs) has long been desired in tissue regeneration and pharmaceutical assays. In particular, in vitro construction of 3D-iPSC-CM tissues with blood capillary networks have attracted much attention because blood capillaries are crucial for nutrient and oxygen supplies for CMs. Blood capillaries in 3D-iPSC-CM tissues will also be important for in vitro toxicity assay of prodrugs because of the signaling interaction between cardiomyocytes and endothelial cells. Here, we report construction of vascularized 3D-iPSC-CM tissues by a newly-discovered filtration-Layer-by-Layer (LbL) technique for cells, instead of our previous centrifugation-LbL technique. The filtration-LbL allowed us to fabricate nanometer-sized extracellular matrices (ECM), fibronectin and gelatin (FN-G), films onto iPSC-CM surfaces without any damage and with high yield, although centrifugation-LbL induced physical stress and a lower yield. The fabricated FN-G nanofilms interacted with integrin molecules on the cell membrane to construct 3D-tissues. We found that the introduction of normal human cardiac fibroblasts (NHCFs) into the iPSC-CM tissues modulated organization and synchronous beating depending on NHCF ratios. Moreover, co-culture with normal human cardiac microvascular endothelial cells (NHCMECs) successfully provided blood capillary-like networks in 3D-iPSC-CM tissues, depending on NHCF ratios. The vascularized 3D-iPSC-CM tissues indicated significantly different toxicity responses as compared to 2D-iPSC-CM cells by addition of doxorubicin as a model of a toxic drug. The constructed vascularized 3D-iPSC-CM tissues would be a promising tool for tissue regeneration and drug development. STATEMENT OF SIGNIFICANCE: In vitro fabrication of vascularized three-dimensional (3D) human cardiomyocyte (CM) tissues derived from human induced pluripotent stem cells (iPSCs) has attracted much attention owing to their requirement of much amount of nutrition and oxygen, but not yet published. In this manuscript, we report construction of vascularized 3D-iPSC-CM tissues by a newly-discovered filtration-Layer-by-Layer (LbL) technique. The filtration-LbL fabricates nanometer-sized fibronectin and gelatin (FN-G) films onto iPSC-CM surfaces. The FN-G nanofilms induce cell-cell interactions via integrin molecules on cell surfaces, leading to construction of 3D-tissues. The constructed vascularized 3D-iPSC-CM tissues would be a promising tool for tissue regeneration and drug development. We believe that this manuscript has a strong impact and offers important suggestions to researchers concerned with biomaterials and tissue engineering.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  3D-tissues; Cardiomyocyte; Drug development; Layer-by-Layer assembly; Tissue engineering; iPS cells

Mesh:

Substances:

Year:  2016        PMID: 26821339     DOI: 10.1016/j.actbio.2016.01.033

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  32 in total

Review 1.  Towards Three-Dimensional Dynamic Regulation and In Situ Characterization of Single Stem Cell Phenotype Using Microfluidics.

Authors:  Sébastien Sart; Spiros N Agathos
Journal:  Mol Biotechnol       Date:  2018-11       Impact factor: 2.695

Review 2.  Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources.

Authors:  Kai Wang; Ruei-Zeng Lin; Juan M Melero-Martin
Journal:  Cell Mol Life Sci       Date:  2018-10-12       Impact factor: 9.261

3.  A cardiac patch from aligned microvessel and cardiomyocyte patches.

Authors:  Jeremy A Schaefer; Pilar A Guzman; Sonja B Riemenschneider; Timothy J Kamp; Robert T Tranquillo
Journal:  J Tissue Eng Regen Med       Date:  2017-11-23       Impact factor: 3.963

4.  Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness.

Authors:  Soah Lee; Vahid Serpooshan; Xinming Tong; Sneha Venkatraman; Meelim Lee; Jaecheol Lee; Orlando Chirikian; Joseph C Wu; Sean M Wu; Fan Yang
Journal:  Biomaterials       Date:  2017-03-30       Impact factor: 12.479

Review 5.  Cell armor for protection against environmental stress: Advances, challenges and applications in micro- and nanoencapsulation of mammalian cells.

Authors:  Onur Hasturk; David L Kaplan
Journal:  Acta Biomater       Date:  2018-11-24       Impact factor: 8.947

6.  Synthesis and Characterization of Silk Ionomers for Layer-by-Layer Electrostatic Deposition on Individual Mammalian Cells.

Authors:  Onur Hasturk; Jugal Kishore Sahoo; David L Kaplan
Journal:  Biomacromolecules       Date:  2020-06-24       Impact factor: 6.988

Review 7.  Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.

Authors:  Nazish Sayed; Mohamed Ameen; Joseph C Wu
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 8.  Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.

Authors:  Alec S T Smith; Jesse Macadangdang; Winnie Leung; Michael A Laflamme; Deok-Ho Kim
Journal:  Biotechnol Adv       Date:  2016-12-20       Impact factor: 14.227

Review 9.  Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?

Authors:  Jonathan P Stack; Javid Moslehi; Nazish Sayed; Joseph C Wu
Journal:  Eur Heart J       Date:  2019-06-07       Impact factor: 29.983

Review 10.  Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.

Authors:  Magali Seguret; Eva Vermersch; Charlène Jouve; Jean-Sébastien Hulot
Journal:  Biomedicines       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.